Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-25 @ 2:44 PM
Study NCT ID:
NCT04369950
Status:
COMPLETED
Last Update Posted:
2022-05-26
First Post:
2020-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
Sponsor:
The University of Texas Health Science Center, Houston
Organization:
Study Overview
Official Title:
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
Status:
COMPLETED
Status Verified Date:
2022-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to show that the effect of 3% 2-chloroprocaine prior to epidural morphine administration will be not inferior to the effect of epidural 2% lidocaine with 1:200,000 epinephrine on total opioid use for 24h
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: